Skip to main content
Top
Published in: Journal of Inflammation 1/2013

Open Access 01-12-2013 | Research

BMP4 is increased in the aortas of diabetic ApoE knockout mice and enhances uptake of oxidized low density lipoprotein into peritoneal macrophages

Authors: Mitsuhisa Koga, Atsushi Yamauchi, Yuki Kanaoka, Ryusuke Jige, Anna Tsukamoto, Nao Teshima, Tsuyoshi Nishioku, Yasufumi Kataoka

Published in: Journal of Inflammation | Issue 1/2013

Login to get access

Abstract

Background

BMP4, a member of the transforming growth factor-beta superfamily, is upregulated in the aortas of diabetic db/db mice. However, little is known about its role in diabetic atherosclerosis. Therefore, we examined the roles of BMP4 in the formation of diabetic atherosclerosis in apolipoprotein E knockout (ApoE KO) mice and in the uptake of oxidized low density lipoprotein (oxLDL) in peritoneal macrophages of wild-type mice.

Methods

To induce diabetes, ApoE KO mice were intraperitoneally injected with streptozotocin. Diabetic and non-diabetic ApoE KO mice were then fed a high-fat diet for 4 weeks. Next, to investigate a role of BMP4 in the peritoneal macrophages, we examined the uptake of oxLDL in BMP4-treated macrophages.

Results

Diabetic ApoE KO mice showed accelerated progression of aortic plaques accompanied by increased luminal plaque area. Western blot analysis showed that BMP4 expression in the whole aorta was greatly increased in diabetic ApoE KO mice, than non-diabetic mice. Western blot analysis showed that the BMP4/SMAD1/5/8 signaling pathway was strongly activated in the aorta from diabetic ApoE KO mice, compared with control ApoE KO mice. Double immunofluorescence staining showed that BMP4 was expressed in MOMA2-labeled macrophage in the aortic lesions of ApoE KO mice. BMP4 significantly increased the uptake of oxLDL into peritoneal macrophages in vitro.

Conclusion

We show that in the aorta of diabetic ApoE KO mice, BMP4 is increased and activates SMAD1/5/8. Our in vitro findings indicate that BMP4 enhances oxLDL uptake in mouse peritoneal macrophages, suggesting BMP4 may be involved in aortic plaque formation in diabetic ApoE KO mice. Targeting BMP4 may offer a new strategy for inhibition of plaque progression and stabilization of atherosclerotic lesions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339: 229-234. 10.1056/NEJM199807233390404.PubMedCrossRef Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339: 229-234. 10.1056/NEJM199807233390404.PubMedCrossRef
2.
go back to reference Mitra S, Goyal T, Mehta JL: Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther. 2011, 25: 419-429. 10.1007/s10557-011-6341-5.PubMedCrossRef Mitra S, Goyal T, Mehta JL: Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther. 2011, 25: 419-429. 10.1007/s10557-011-6341-5.PubMedCrossRef
3.
go back to reference Yla-Herttuala S: Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Ann Med. 1991, 23: 561-567. 10.3109/07853899109150518.PubMedCrossRef Yla-Herttuala S: Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Ann Med. 1991, 23: 561-567. 10.3109/07853899109150518.PubMedCrossRef
4.
go back to reference Jialal I, Devaraj S: The role of oxidized low density lipoprotein in atherogenesis. J Nutr. 1996, 126: 1053S-1057S.PubMed Jialal I, Devaraj S: The role of oxidized low density lipoprotein in atherogenesis. J Nutr. 1996, 126: 1053S-1057S.PubMed
5.
go back to reference Frostegard J, Nilsson J, Haegerstrand A, Hamsten A, Wigzell H, Gidlund M: Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci U S A. 1990, 87: 904-908. 10.1073/pnas.87.3.904.PubMedPubMedCentralCrossRef Frostegard J, Nilsson J, Haegerstrand A, Hamsten A, Wigzell H, Gidlund M: Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci U S A. 1990, 87: 904-908. 10.1073/pnas.87.3.904.PubMedPubMedCentralCrossRef
6.
go back to reference Frostegard J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J: Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb. 1992, 12: 461-467. 10.1161/01.ATV.12.4.461.PubMedCrossRef Frostegard J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J: Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb. 1992, 12: 461-467. 10.1161/01.ATV.12.4.461.PubMedCrossRef
7.
go back to reference Chen D, Zhao M, Mundy GR: Bone morphogenetic proteins. Growth Factors. 2004, 22: 233-241. 10.1080/08977190412331279890.PubMedCrossRef Chen D, Zhao M, Mundy GR: Bone morphogenetic proteins. Growth Factors. 2004, 22: 233-241. 10.1080/08977190412331279890.PubMedCrossRef
8.
go back to reference Massague J, Chen YG: Controlling TGF-beta signaling. Genes Dev. 2000, 14: 627-644.PubMed Massague J, Chen YG: Controlling TGF-beta signaling. Genes Dev. 2000, 14: 627-644.PubMed
9.
go back to reference Ebendal T, Bengtsson H, Soderstrom S: Bone morphogenetic proteins and their receptors: potential functions in the brain. J Neurosci Res. 1998, 51: 139-146. 10.1002/(SICI)1097-4547(19980115)51:2<139::AID-JNR2>3.0.CO;2-E.PubMedCrossRef Ebendal T, Bengtsson H, Soderstrom S: Bone morphogenetic proteins and their receptors: potential functions in the brain. J Neurosci Res. 1998, 51: 139-146. 10.1002/(SICI)1097-4547(19980115)51:2<139::AID-JNR2>3.0.CO;2-E.PubMedCrossRef
10.
go back to reference Graff JM: Embryonic patterning: to BMP or not to BMP, that is the question. Cell. 1997, 89: 171-174. 10.1016/S0092-8674(00)80196-8.PubMedCrossRef Graff JM: Embryonic patterning: to BMP or not to BMP, that is the question. Cell. 1997, 89: 171-174. 10.1016/S0092-8674(00)80196-8.PubMedCrossRef
11.
go back to reference Hogan BL: Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 1996, 10: 1580-1594. 10.1101/gad.10.13.1580.PubMedCrossRef Hogan BL: Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 1996, 10: 1580-1594. 10.1101/gad.10.13.1580.PubMedCrossRef
12.
go back to reference Kiyono M, Shibuya M: Bone morphogenetic protein 4 mediates apoptosis of capillary endothelial cells during rat pupillary membrane regression. Mol Cell Biol. 2003, 23: 4627-4636. 10.1128/MCB.23.13.4627-4636.2003.PubMedPubMedCentralCrossRef Kiyono M, Shibuya M: Bone morphogenetic protein 4 mediates apoptosis of capillary endothelial cells during rat pupillary membrane regression. Mol Cell Biol. 2003, 23: 4627-4636. 10.1128/MCB.23.13.4627-4636.2003.PubMedPubMedCentralCrossRef
13.
go back to reference Wozney JM, Rosen V: Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res. 1998, 346: 26-37.PubMed Wozney JM, Rosen V: Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res. 1998, 346: 26-37.PubMed
14.
go back to reference Derwall M, Malhotra R, Lai CS, Beppu Y, Aikawa E, Seehra JS, Zapol WM, Bloch KD, Yu PB: Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol. 2012, 32: 613-622. 10.1161/ATVBAHA.111.242594.PubMedCrossRef Derwall M, Malhotra R, Lai CS, Beppu Y, Aikawa E, Seehra JS, Zapol WM, Bloch KD, Yu PB: Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol. 2012, 32: 613-622. 10.1161/ATVBAHA.111.242594.PubMedCrossRef
15.
go back to reference San Martin A, Du P, Dikalova A, Lassegue B, Aleman M, Gongora MC, Brown K, Joseph G, Harrison DG, Taylor WR: Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. Am J Physiol Heart Circ Physiol. 2007, 292: H2073-H2082. 10.1152/ajpheart.00943.2006.PubMedCrossRef San Martin A, Du P, Dikalova A, Lassegue B, Aleman M, Gongora MC, Brown K, Joseph G, Harrison DG, Taylor WR: Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. Am J Physiol Heart Circ Physiol. 2007, 292: H2073-H2082. 10.1152/ajpheart.00943.2006.PubMedCrossRef
16.
go back to reference Shao JS, Cai J, Towler DA: Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol. 2006, 26: 1423-1430. 10.1161/01.ATV.0000220441.42041.20.PubMedCrossRef Shao JS, Cai J, Towler DA: Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol. 2006, 26: 1423-1430. 10.1161/01.ATV.0000220441.42041.20.PubMedCrossRef
17.
go back to reference Sorescu GP, Sykes M, Weiss D, Platt MO, Saha A, Hwang J, Boyd N, Boo YC, Vega JD, Taylor WR, Jo H: Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J Biol Chem. 2003, 278: 31128-31135. 10.1074/jbc.M300703200.PubMedCrossRef Sorescu GP, Sykes M, Weiss D, Platt MO, Saha A, Hwang J, Boyd N, Boo YC, Vega JD, Taylor WR, Jo H: Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J Biol Chem. 2003, 278: 31128-31135. 10.1074/jbc.M300703200.PubMedCrossRef
18.
go back to reference Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ: Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001, 21: 1998-2003. 10.1161/hq1201.100229.PubMedCrossRef Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ: Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001, 21: 1998-2003. 10.1161/hq1201.100229.PubMedCrossRef
19.
go back to reference Vendrov AE, Madamanchi NR, Hakim ZS, Rojas M, Runge MS: Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis. Circ Res. 2006, 98: 1254-1263. 10.1161/01.RES.0000221214.37803.79.PubMedCrossRef Vendrov AE, Madamanchi NR, Hakim ZS, Rojas M, Runge MS: Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis. Circ Res. 2006, 98: 1254-1263. 10.1161/01.RES.0000221214.37803.79.PubMedCrossRef
20.
go back to reference Miriyala S, Gongora Nieto MC, Mingone C, Smith D, Dikalov S, Harrison DG, Jo H: Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation. 2006, 113: 2818-2825. 10.1161/CIRCULATIONAHA.106.611822.PubMedCrossRef Miriyala S, Gongora Nieto MC, Mingone C, Smith D, Dikalov S, Harrison DG, Jo H: Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation. 2006, 113: 2818-2825. 10.1161/CIRCULATIONAHA.106.611822.PubMedCrossRef
21.
go back to reference Chang K, Weiss D, Suo J, Vega JD, Giddens D, Taylor WR, Jo H: Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: role of bone morphogenic protein antagonists in inflammation and atherosclerosis. Circulation. 2007, 116: 1258-1266. 10.1161/CIRCULATIONAHA.106.683227.PubMedCrossRef Chang K, Weiss D, Suo J, Vega JD, Giddens D, Taylor WR, Jo H: Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: role of bone morphogenic protein antagonists in inflammation and atherosclerosis. Circulation. 2007, 116: 1258-1266. 10.1161/CIRCULATIONAHA.106.683227.PubMedCrossRef
22.
go back to reference Ding H, Hashem M, Wiehler WB, Lau W, Martin J, Reid J, Triggle C: Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse. Br J Pharmacol. 2005, 146: 1110-1118.PubMedPubMedCentralCrossRef Ding H, Hashem M, Wiehler WB, Lau W, Martin J, Reid J, Triggle C: Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse. Br J Pharmacol. 2005, 146: 1110-1118.PubMedPubMedCentralCrossRef
23.
go back to reference Goldberg IJ, Hu Y, Noh HL, Wei J, Huggins LA, Rackmill MG, Hamai H, Reid BN, Blaner WS, Huang LS: Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes. Diabetes. 2008, 57: 1674-1682. 10.2337/db08-0083.PubMedCrossRef Goldberg IJ, Hu Y, Noh HL, Wei J, Huggins LA, Rackmill MG, Hamai H, Reid BN, Blaner WS, Huang LS: Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes. Diabetes. 2008, 57: 1674-1682. 10.2337/db08-0083.PubMedCrossRef
24.
go back to reference Koga M, Kai H, Yasukawa H, Yamamoto T, Kawai Y, Kato S, Kusaba K, Kai M, Egashira K, Kataoka Y, Imaizumi T: Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice. Circ Res. 2007, 101: 348-356. 10.1161/CIRCRESAHA.106.147256.PubMedCrossRef Koga M, Kai H, Yasukawa H, Yamamoto T, Kawai Y, Kato S, Kusaba K, Kai M, Egashira K, Kataoka Y, Imaizumi T: Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice. Circ Res. 2007, 101: 348-356. 10.1161/CIRCRESAHA.106.147256.PubMedCrossRef
25.
go back to reference Koga M, Kai H, Yasukawa H, Kato S, Yamamoto T, Kawai Y, Kusaba K, Seki Y, Kai M, Egashira K: Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice. Hypertens Res. 2007, 30: 259-267. 10.1291/hypres.30.259.PubMedCrossRef Koga M, Kai H, Yasukawa H, Kato S, Yamamoto T, Kawai Y, Kusaba K, Seki Y, Kai M, Egashira K: Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice. Hypertens Res. 2007, 30: 259-267. 10.1291/hypres.30.259.PubMedCrossRef
26.
go back to reference Shaw DR, Griffin FM: Thioglycollate-elicited mouse peritoneal macrophages are less efficient than resident macrophages in antibody-dependent cell-mediated cytolysis. J Immunol. 1982, 128: 433-440.PubMed Shaw DR, Griffin FM: Thioglycollate-elicited mouse peritoneal macrophages are less efficient than resident macrophages in antibody-dependent cell-mediated cytolysis. J Immunol. 1982, 128: 433-440.PubMed
27.
go back to reference Slavina ES, Madanat A, Pankov Yu A, Syrkin AL, Tertov VV, Orekhov AN: Diabetes mellitus and atherosclerosis. N Engl J Med. 1987, 317: 836-PubMed Slavina ES, Madanat A, Pankov Yu A, Syrkin AL, Tertov VV, Orekhov AN: Diabetes mellitus and atherosclerosis. N Engl J Med. 1987, 317: 836-PubMed
28.
go back to reference Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005, 352: 1685-1695. 10.1056/NEJMra043430.PubMedCrossRef Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005, 352: 1685-1695. 10.1056/NEJMra043430.PubMedCrossRef
30.
go back to reference Ross R: Atherosclerosis is an inflammatory disease. Am Heart J. 1999, 138: S419-S420. 10.1016/S0002-8703(99)70266-8.PubMedCrossRef Ross R: Atherosclerosis is an inflammatory disease. Am Heart J. 1999, 138: S419-S420. 10.1016/S0002-8703(99)70266-8.PubMedCrossRef
31.
go back to reference Ross R: Atherosclerosis–an inflammatory disease. N Engl J Med. 1999, 340: 115-126. 10.1056/NEJM199901143400207.PubMedCrossRef Ross R: Atherosclerosis–an inflammatory disease. N Engl J Med. 1999, 340: 115-126. 10.1056/NEJM199901143400207.PubMedCrossRef
32.
33.
go back to reference Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, Hayabuchi N, Imaizumi T: Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006, 48: 1825-1831. 10.1016/j.jacc.2006.03.069.PubMedCrossRef Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, Hayabuchi N, Imaizumi T: Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006, 48: 1825-1831. 10.1016/j.jacc.2006.03.069.PubMedCrossRef
34.
go back to reference Bostrom KI, Jumabay M, Matveyenko A, Nicholas SB, Yao Y: Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ Res. 2011, 108: 446-457. 10.1161/CIRCRESAHA.110.236596.PubMedPubMedCentralCrossRef Bostrom KI, Jumabay M, Matveyenko A, Nicholas SB, Yao Y: Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ Res. 2011, 108: 446-457. 10.1161/CIRCRESAHA.110.236596.PubMedPubMedCentralCrossRef
35.
go back to reference Yao Y, Shao ES, Jumabay M, Shahbazian A, Ji S, Bostrom KI: High-density lipoproteins affect endothelial BMP-signaling by modulating expression of the activin-like kinase receptor 1 and 2. Arterioscler Thromb Vasc Biol. 2008, 28: 2266-2274. 10.1161/ATVBAHA.108.176958.PubMedPubMedCentralCrossRef Yao Y, Shao ES, Jumabay M, Shahbazian A, Ji S, Bostrom KI: High-density lipoproteins affect endothelial BMP-signaling by modulating expression of the activin-like kinase receptor 1 and 2. Arterioscler Thromb Vasc Biol. 2008, 28: 2266-2274. 10.1161/ATVBAHA.108.176958.PubMedPubMedCentralCrossRef
Metadata
Title
BMP4 is increased in the aortas of diabetic ApoE knockout mice and enhances uptake of oxidized low density lipoprotein into peritoneal macrophages
Authors
Mitsuhisa Koga
Atsushi Yamauchi
Yuki Kanaoka
Ryusuke Jige
Anna Tsukamoto
Nao Teshima
Tsuyoshi Nishioku
Yasufumi Kataoka
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2013
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-10-32

Other articles of this Issue 1/2013

Journal of Inflammation 1/2013 Go to the issue